Intronic TP53 Germline Sequence Variants Modify the Risk in German Breast/Ovarian Cancer Families

Hereditary Cancer in Clinical Practice

Volumn 2, Issue 3, 2004, Pages

  Liu, Xuan ^a,b   Sinn, Hans Peter ^c   Ulmer, Hans Ulrich ^d   Scott, Rodney J ^e   Hamann, Ute ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b University of Chinese Medicine   (China)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^e UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

familial breast ovarian cancer; germline mutations; polymorphisms; TP53

Indexed keywords

EID: 64849097085     PISSN: 17312302     EISSN: 18974287     Source Type: Journal    
DOI: 10.1186/1897-4287-2-3-139     Document Type: Article

References (40)

1. D.M. Parkin P. Pisani J. Ferlay Estimates of the worldwide incidence of 25 major cancers in 1990 Int J Cancer 1999 80 827 841 10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P 1:STN:280:DyaK1M7ntlajuw%3D%3D 10074914
2. D. Ford D.F. Easton M. Stratton S. Narod D. Goldgar P. Devilee D.T. Bishop B. Weber G. Lenoir J. Chang-Claude H. Sobol M.D. Teare J. Struewing A. Arason S. Scherneck J. Peto T.R. Rebbeck P. Tonin S. Neuhausen R. Barkardottir J. Eyfjord H. Lynch B.A. Ponder S.A. Gayther M. Zelada-Hedman Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am J Hum Genet 1998 62 676 689 1376944 10.1086/301749 1:CAS:528:DyaK1MXlvFeh 9497246
3. Y. Miki J. Swensen D. Shattuck-Eidens P.A. Futreal K. Harshman S. Tavtigian Q. Liu C. Cochran L.M. Bennett W. Ding A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 1994 266 66 71 10.1126/science.7545954 1:CAS:528:DyaK2MXhtF2ns70%3D 7545954
4. R. Wooster S.L. Neuhausen J. Mangion Y. Quirk D. Ford N. Collins K. Nguyen S. Seal T. Tran D. Averill Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13 Science 1994 265 2088 2090 10.1126/science.8091231 1:CAS:528:DyaK2cXmsFejsLY%3D 8091231
5. R. Wooster G. Bignell J. Lancaster S. Swift S. Seal J. Mangion N. Collins S. Gregory C. Gumbs G. Micklem Identification of the breast cancer susceptibility gene BRCA2 Nature 1995 378 789 792 10.1038/378789a0 1:CAS:528:DyaK28XltFWi 8524414
6. D.F. Easton How many more breast cancer predisposition genes are there? Breast Cancer Res 1999 1 14 17 138504 10.1186/bcr6 1:CAS:528:DC%2BD3cXlsFKgs7s%3D 11250676
7. D. Malkin F.P. Li L.C. Strong J.F. Fraumeni Jr C.E. Nelson D.H. Kim J. Kassel M.A. Gryka F.Z. Bischoff M.A. Tainsky Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science 1990 250 1233 1238 10.1126/science.1978757 1:CAS:528:DyaK3MXjslSisw%3D%3D 1978757
8. S. Srivastava Z.Q. Zou K. Pirollo W. Blattner E.H. Chang Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome Nature 1990 348 747 749 10.1038/348747a0 1:CAS:528:DyaK3MXls1OnsQ%3D%3D 2259385
9. A.L. Borresen T.I. Andersen J. Garber N. Barbier-Piraux S. Thorlacius J. Eyfjord L. Ottestad B. Smith-Sorensen E. Hovig D. Malkin Screening for germ line TP53 mutations in breast cancer patients Cancer Res 1992 52 3234 3236 1:STN:280:DyaK383nsVeqsg%3D%3D 1591732
10. R.S. Cornelis M. van Vliet M.D. Vijver MJvan de H.F. Vasen P.A. Voute B. Top P.M. Khan P. Devilee C.J. Cornelisse Three germline mutations in the TP53 gene Hum Mutat 1997 9 157 163 10.1002/(SICI)1098-1004(1997)9:2<157::AID-HUMU8>3.0.CO;2-6 1:CAS:528:DyaK2sXhvFOkurw%3D 9067756
11. K.W. Jolly D. Malkin E.C. Douglass T.F. Brown A.E. Sinclair A.T. Look Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer Oncogene 1994 9 97 102 1:CAS:528:DyaK2cXhtVemt7s%3D 8302608
12. J. Prosser D. Porter C. Coles A. Condie A.M. Thompson U. Chetty C.M. Steel H.J. Evans Constitutional p53 mutation in a non-Li-Fraumeni cancer family Br J Cancer 1992 65 527 528 1977555 10.1038/bjc.1992.109 1:STN:280:DyaK383it1yntQ%3D%3D 1562462
13. D. Sidransky E. Messing Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factors Urol Clin North Am 1992 19 629 639 1:STN:280:DyaK3s%2FmvFOhsg%3D%3D 1441021
14. X.F. Sun O. Johannsson S. Hakansson G. Sellberg B. Nordenskjold H. Olsson A. Borg A novel p53 germline alteration identified in a late onset breast cancer kindred Oncogene 1996 13 407 411 1:CAS:528:DyaK28XkvVSqur0%3D 8710380
15. J.M. Varley D.G. Evans J.M. Birch Li-Fraumeni syndrome - a molecular and clinical review Br J Cancer 1997 76 1 14 2223793 10.1038/bjc.1997.328 1:CAS:528:DyaK2sXkslaiu7Y%3D 9218725
16. G. Lozano A.J. Levine Tissue-specific expression of p53 in transgenic mice is regulated by intron sequences Mol Carcinogen 1991 4 3 9 10.1002/mc.2940040103 1:CAS:528:DyaK3MXktVahsbg%3D
17. J.M. Varley P. Chapman G. McGown M. Thorncroft G.R. White M.J. Greaves D. Scott A. Spreadborough K.J. Tricker J.M. Birch D.G. Evans R. Reddel R.S. Camplejohn J. Burn J.M. Boyle Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family Oncogene 1998 16 3291 3298 10.1038/sj.onc.1201878 1:CAS:528:DyaK1cXksFSlsLo%3D 9681828
18. T.A. Lehman B.G. Haffty C.J. Carbone L.R. Bishop A.A. Gumbs S. Krishnan P.G. Shields R. Modali B.C. Turner Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer Cancer Res 2000 60 1062 1069 1:CAS:528:DC%2BD3cXhs1ShsLk%3D 10706125
19. U. Hamann M. Haner U. Stosiek G. Bastert R.J. Scott Low frequency of BRCA1 germline mutations in 45 German breast/ovarian cancer families J Med Genet 1997 34 884 888 1051113 10.1136/jmg.34.11.884 1:STN:280:DyaK1c%2FltleltQ%3D%3D 9391879
20. U. Hamann H. Brauch A.M. Garvin G. Bastert R.J. Scott German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene Genes Chromosomes Cancer 1997 18 126 132 10.1002/(SICI)1098-2264(199702)18:2<126::AID-GCC7>3.0.CO;2-4 1:CAS:528:DyaK2sXhsVOisLs%3D 9115962
21. U. Hamann H.P. Sinn Survival and tumor characteristics of German hereditary breast cancer patients Breast Cancer Res Treat 2000 59 185 192 10.1023/A:1006350518190 1:STN:280:DC%2BD3c3nsFSmtw%3D%3D 10817354
22. U. Hamann X. Liu S. Lange H.U. Ulmer A. Benner R.J. Scott Contribution of BRCA2 germline mutations to hereditary breast/ovarian cancer in Germany J Med Genet 2002 39 E12 1735066 10.1136/jmg.39.3.e12 1:STN:280:DC%2BD387otFSiug%3D%3D 11897832
23. B. Jandrig K. Grade S. Seitz B. Waindzoch M. Muller E. Bender A. Nothnagel K. Rohde P.M. Schlag R. Kath K. Hoffken S. Scherneck BRCA1 mutations in German breast-cancer families Int J Cancer 1996 68 188 192 10.1002/(SICI)1097-0215(19961009)68:2<188::AID-IJC8>3.0.CO;2-U 1:CAS:528:DyaK28XntlKjtbY%3D 8900426
24. U. Hamann H. Becher T. Zimmermann K. Pella G. Bastert J. Chang-Claude German family study on hereditary breast-ovarian cancer J Med Genet 1996 33 633 635 1050694 10.1136/jmg.33.8.633 1:STN:280:DyaK2s%2Fhs1GhtA%3D%3D 8863152
25. J.M. Birch A.L. Hartley K.J. Tricker J. Prosser A. Condie A.M. Kelsey M. Harris P.H. Jones A. Binchy D. Crowther Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families Cancer Res 1994 54 1298 1304 1:CAS:528:DyaK2cXitFCjsbY%3D 8118819
26. J.M. Varley G. McGown M. Thorncroft L.A. James G.P. Margison G. Forster D.G. Evans M. Harris A.M. Kelsey J.M. Birch Are there low-penetrance TP53 Alleles? Evidence from childhood adrenocortical tumors Am J Hum Genet 1999 65 995 1006 1288270 10.1086/302575 1:STN:280:DC%2BD3cvnsFerug%3D%3D 10486318
27. S.C. Evans B. Mims K.M. McMasters C.J. Foster M. deAndrade C.I. Amos L.C. Strong G. Lozano Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family Hum Genet 1998 102 681 686 10.1007/s004390050761 1:CAS:528:DyaK1cXktFKltrw%3D 9703430
28. R. Emig A. Magener V. Ehemann A. Meyer F. Stilgenbauer M. Volkmann D. Wallwiener H.P. Sinn Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation Br J Cancer 1998 78 1661 1668 2063248 10.1038/bjc.1998.739 1:CAS:528:DyaK1MXhslKltQ%3D%3D 9862580
29. R.E. Buller J.S. Skilling S. Kaliszewski T. Niemann B. Anderson Absence of significant germ line p53 mutations in ovarian cancer patients Gynecol Oncol 1995 58 368 374 10.1006/gyno.1995.1244 1:CAS:528:DyaK2MXoslejsbc%3D 7672703
30. S. Sjogren M. Inganas T. Norberg A. Lindgren H. Nordgren L. Holmberg J. Bergh The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry J Natl Cancer Inst 1996 88 173 182 10.1093/jnci/88.3-4.173 1:STN:280:DyaK283jtF2gsA%3D%3D 8632491
31. S. Hillebrandt C. Streffer E.P. Demidchik J. Biko C. Reiners Polymorphisms in the p53 gene in thyroid tumours and blood samples of children from areas in Belarus Mutat Res 1997 381 201 207 10.1016/S0027-5107(97)00169-3 1:CAS:528:DyaK2sXns1Wnu70%3D 9434876
32. A. Marsh A.B. Spurdle B.C. Turner S. Fereday H. Thorne G.M. Pupo G.J. Mann J.L. Hopper J.F. Sambrook G. Chenevix-Trench The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia Breast Cancer Res 2001 3 346 349 57805 10.1186/bcr319 1:CAS:528:DC%2BD3MXntlegtrw%3D 11597326
33. L. Fiszer-Maliszewska B. Kazanowska P. Kusnierczyk M. Manczak W. Niepieklo B. Pochron-Zeman B. Nowakowska Is p53 intronic variant G13964C associated with predisposition to cancer? J Appl Genet 2003 44 547 552 14617836
34. S. Avigad D. Barel O. Blau A. Malka M. Zoldan C. Mor M. Fogel I.J. Cohen B. Stark Y. Goshen J. Stein R. Zaizov A novel germ line p53 mutation in intron 6 in diverse childhood malignancies Oncogene 1997 14 1541 1545 10.1038/sj.onc.1200990 1:CAS:528:DyaK2sXislKmsLY%3D 9129144
35. D. Barel S. Avigad C. Mor M. Fogel I.J. Cohen R. Zaizov A novel germ-line mutation in the noncoding region of the p53 gene in a Li-Fraumeni family Cancer Genet Cytogenet 1998 103 1 6 10.1016/S0165-4608(97)00258-6 1:CAS:528:DyaK1cXjtVansrY%3D 9595036
36. T. McDaniel D. Carbone T. Takahashi P. Chumakov E.H. Chang K.F. Pirollo J. Yin Y. Huang S.J. Meltzer The MspI polymorphism in intron 6 of p53 (TP53) detected by digestion of PCR products Nucleic Acids Res 1991 19 4796 328758 10.1093/nar/19.17.4796-a 1:CAS:528:DyaK3MXmtVShsr0%3D 1716362
37. S. Peller Y. Kopilova S. Slutzki A. Halevy K. Kvitko V. Rotter A novel polymorphism in intron 6 of the human p53 gene: a possible association with cancer predisposition and susceptibility DNA Cell Biol 1995 14 983 990 10.1089/dna.1995.14.983 1:CAS:528:DyaK28XitFCkug%3D%3D 8534372
38. A.N. Magewu P.A. Jones Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer Mol Cell Biol 1994 14 4225 4232 358788 10.1128/MCB.14.6.4225 1:CAS:528:DyaK2cXktlaiurg%3D 8196660
39. Breast Cancer Information Core (BIC) database2004. [http://www.nhgri.nih.gov/Intramural_research/Lab_transfer/Bic/]
40. UICC L.H. Sobin C. Wittekind Ch TNM classification of malignant tumours 1997 5 New York Wiley & Sons